COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,187 Articles (22,713 medRxiv, 8,474 bioRxiv)

Most recent first Previous |  Page 121: Articles 1201-1210  | Next

Adapting COVID-19 research infrastructure to capture influenza and respiratory syncytial virus alongside SARS-CoV-2 in UK healthcare workers winter 2022/23: Results of a pilot study in the SIREN cohort
Foulkes, S., Munro, K., Sparkes, D., Broad, J., Platt, N., Howells, A., Akinbami, O., Khawam, J., Joshi, P., Russell, S., Norman, C., Price, L., Corrigan, D., Cole, M., Timeyin, J., Forster, L., Slater, K., Watson, C. H., Andrews, N., Charlett, A., Atti, A., Islam, J., Brown, C. S., Turner, J., Hopkins, S., Hall, V., SIREN Study Group
10.1101/2024.12.09.24318698 — Posted: 2024-12-10
Structural and Functional Insights into the Evolution of SARS-CoV-2 KP.3.1.1 Spike Protein
Feng, Z., Huang, J., Baboo, S., Diedrich, J. K., Bangaru, S., Paulson, J. C., Yates, J. R., Yuan, M., Wilson, I. A., Ward, A. B.
10.1101/2024.12.10.627775 — Posted: 2024-12-10
Differential control of mycobacteria among COVID-19 patients is associated with CD28+ CD8+ T cells
Llibre, A., Siddiqui, H., Pillaye, J., Burel, J., Jones, C., Hill, H., Faustini, S. E., Windle, E., Karim, H., Sherry, E., Green, C. A., Dedicoat, M., Stamataki, Z., Cunningham, A. F., O'Shea, M. K.
10.1101/2024.12.09.626962 — Posted: 2024-12-10
Longitudinal cellular and humoral immune responses following Covid-19 BNT162b2-mRNA-based booster vaccination of craft and manual workers in Qatar.
Thomas, R., Zaqout, A., Meqbel, B., Jafar, U., Vaikath, N., Aldushain, A., Naik, A., Shaath, H., Al-Akl, N. S., Adam, A., Ali Moussa, H. Y., Shin, K. C., Taha, R. Z., Abukhattab, M., Almaslamani, M. A., Alajez, N. M., Arredouani, A., Park, Y., Abdulla, S. A., El-Agnaf, O. M., Omrani, A. S., Decock, J.
10.1101/2024.12.10.627725 — Posted: 2024-12-10
Accelerated amyloid deposition in SARS-CoV-2 infected mouse models of Alzheimer's disease
Parekh, P. A., Badachhape, A. A., Redd, J. R., Bonilla, L. J., Bhandari, P., Kneubehl, A. R., Bhavane, R., Clinton, J. L. S., Admane, P., Menon, R., Srivastava, M., Sun, X., Narang, S., Tanifum, E., Ghaghada, K. B., Ronca, S. E., Annapragada, A. V.
10.1101/2024.12.09.627570 — Posted: 2024-12-10
The SARS-CoV-2 envelope PDZ Binding Motif acts as a virulence factor disrupting host's epithelial cell-cell junctions
Alvarez, F., Melo, G. D. d., Larrous, F., Kergoat, L., Boeda, B., Michel, V., Seilhean, D., Tichit, M., Hing, D., Hardy, D., Kornobis, E., Bourhy, H., Wolff, N., Caillet-Saguy, C.
10.1101/2024.12.10.627528 — Posted: 2024-12-10
SARITA: A Large Language Model for Generating the S1 Subunit of the SARS-CoV-2 Spike Protein
Rancati, S., Nicora, G., Bergomi, L., Buonocore, T. M., Czyz, D. M., Parimbelli, E., Bellazzi, R., Salemi, M., Prosperi, M., Marini, S.
10.1101/2024.12.10.627777 — Posted: 2024-12-10
HIPSTR: highest independent posterior subtree reconstruction in TreeAnnotator X
Baele, G., Carvalho, L. M., Brusselmans, M., Dudas, G., Ji, X., McCrone, J. T., Lemey, P., Suchard, M. A., Rambaut, A.
10.1101/2024.12.08.627395 — Posted: 2024-12-10
Orchestration of SARS-CoV-2 Nsp4 and host-cell ESCRT proteins induces morphological changes of the endoplasmic reticulum
Kifer, A., Pina, F., Codallos, N., Hermann, A., Ziegler, L., Niwa, M.
10.1101/2024.12.08.627411 — Posted: 2024-12-10
Comprehensive Analysis of SARS-CoV-2 Spike Evolution: Epitope Classification and Immune Escape Prediction
Teruel, N. F. B., Crown, M., Rajsbaum, R., Bashton, M., Najmanovich, R.
10.1101/2024.12.06.627164 — Posted: 2024-12-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).